Report Categories Report Categories

Report Categories

industry Category

All

Total: 15 records, 2 pages

HuiJianTou lanJianTou

Global Recombinant Trypsin Supply, Demand and Key Producers, 2024-2030

date 01 Mar 2024

date Pharma & Healthcare

new_biaoQian Recombinant Trypsin

The global Recombinant Trypsin market size is expected to reach $ 52 million by 2030, rising at a market growth of 7.8% CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

Add To Cart

Global Recombinant Trypsin Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

new_biaoQian Recombinant Trypsin

According to our (Global Info Research) latest study, the global Recombinant Trypsin market size was valued at USD 31 million in 2023 and is forecast to a readjusted size of USD 52 million by 2030 with a CAGR of 7.8% during review period.

USD3480.00

Add To Cart

Add To Cart

Global Recombinant Trypsin Powder Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

new_biaoQian Recombinant Trypsin Powder

According to our (Global Info Research) latest study, the global Recombinant Trypsin Powder market size was valued at USD 123.5 million in 2023 and is forecast to a readjusted size of USD 177.9 million by 2030 with a CAGR of 5.4% during review period.

USD3480.00

Add To Cart

Add To Cart

Global Recombinant Trypsin Solution Supply, Demand and Key Producers, 2024-2030

date 10 Feb 2024

date Pharma & Healthcare

new_biaoQian Recombinant Trypsin Solution

The global Recombinant Trypsin Solution market size is expected to reach $ 39 million by 2030, rising at a market growth of 7.3% CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

Add To Cart

Global Recombinant Trypsin Solution Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

new_biaoQian Recombinant Trypsin Solution

According to our (Global Info Research) latest study, the global Recombinant Trypsin Solution market size was valued at USD 24 million in 2023 and is forecast to a readjusted size of USD 39 million by 2030 with a CAGR of 7.3% during review period.

USD3480.00

Add To Cart

Add To Cart

Global Recombinant Trypsin Liquid Solution Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

new_biaoQian Recombinant Trypsin Liquid Solution

According to our (Global Info Research) latest study, the global Recombinant Trypsin Liquid Solution market size was valued at USD 24 million in 2023 and is forecast to a readjusted size of USD 39 million by 2030 with a CAGR of 7.3% during review period.

USD3480.00

Add To Cart

Add To Cart

Global Animal Origin Free Recombinant Trypsin Supply, Demand and Key Producers, 2024-2030

date 07 Apr 2024

date Medical Care

new_biaoQian Animal Origin Free Recombinant Trypsin

Animal origin free recombinant trypsin is an enzyme prepared through genetic engineering technology. It is derived from the pancreas, but it is not extracted from the animal body, but obtained by recombinant expression in microorganisms or other cell systems. This enzyme is widely used in protein engineering, drug synthesis, biochemical research and other fields.

USD4480.00

Add To Cart

Add To Cart

Global Animal Origin Free Recombinant Trypsin Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 07 Apr 2024

date Medical Care

new_biaoQian Animal Origin Free Recombinant Trypsin

Animal origin free recombinant trypsin is an enzyme prepared through genetic engineering technology. It is derived from the pancreas, but it is not extracted from the animal body, but obtained by recombinant expression in microorganisms or other cell systems. This enzyme is widely used in protein engineering, drug synthesis, biochemical research and other fields.

USD3480.00

Add To Cart

Add To Cart

Global Recombinant Trypsin EDTA Solution for Cell Dissociation Supply, Demand and Key Producers, 2024-2030

date 12 Feb 2024

date Medical Devices & Consumables

new_biaoQian Recombinant Trypsin EDTA Solution for Cell Dissociation

The global Recombinant Trypsin EDTA Solution for Cell Dissociation market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

Add To Cart

Global Recombinant Trypsin Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Pharma & Healthcare

new_biaoQian Recombinant Trypsin

Recombinant Trypsin is a genetically engineered protein expressed in E-Coli. As such it is totally animal free, free from contaminating enzymes like chymotrysin as well as protease inhibitors. It is highly stable with a high purity. It is widely used in insulin manufacturing, Vaccines Manufacturing and cell culture applications.

USD3480.00

Add To Cart

Add To Cart

Go To Page

Confirm

industry 01 Mar 2024

industry Pharma & Healthcare

new_biaoQian Recombinant Trypsin

The global Recombinant Trypsin market size is expected to reach $ 52 million by 2030, rising at a market growth of 7.8% CAGR during the forecast period (2024-2030).

USD4480.00

addToCart

Add To Cart

industry 02 Jan 2024

industry Pharma & Healthcare

new_biaoQian Recombinant Trypsin

According to our (Global Info Research) latest study, the global Recombinant Trypsin market size was valued at USD 31 million in 2023 and is forecast to a readjusted size of USD 52 million by 2030 with a CAGR of 7.8% during review period.

USD3480.00

addToCart

Add To Cart

industry 02 Jan 2024

industry Pharma & Healthcare

new_biaoQian Recombinant Trypsin Powder

According to our (Global Info Research) latest study, the global Recombinant Trypsin Powder market size was valued at USD 123.5 million in 2023 and is forecast to a readjusted size of USD 177.9 million by 2030 with a CAGR of 5.4% during review period.

USD3480.00

addToCart

Add To Cart

industry 10 Feb 2024

industry Pharma & Healthcare

new_biaoQian Recombinant Trypsin Solution

The global Recombinant Trypsin Solution market size is expected to reach $ 39 million by 2030, rising at a market growth of 7.3% CAGR during the forecast period (2024-2030).

USD4480.00

addToCart

Add To Cart

industry 02 Jan 2024

industry Pharma & Healthcare

new_biaoQian Recombinant Trypsin Solution

According to our (Global Info Research) latest study, the global Recombinant Trypsin Solution market size was valued at USD 24 million in 2023 and is forecast to a readjusted size of USD 39 million by 2030 with a CAGR of 7.3% during review period.

USD3480.00

addToCart

Add To Cart

industry 02 Jan 2024

industry Pharma & Healthcare

new_biaoQian Recombinant Trypsin Liquid Solution

According to our (Global Info Research) latest study, the global Recombinant Trypsin Liquid Solution market size was valued at USD 24 million in 2023 and is forecast to a readjusted size of USD 39 million by 2030 with a CAGR of 7.3% during review period.

USD3480.00

addToCart

Add To Cart

Animal origin free recombinant trypsin is an enzyme prepared through genetic engineering technology. It is derived from the pancreas, but it is not extracted from the animal body, but obtained by recombinant expression in microorganisms or other cell systems. This enzyme is widely used in protein engineering, drug synthesis, biochemical research and other fields.

USD4480.00

addToCart

Add To Cart

Animal origin free recombinant trypsin is an enzyme prepared through genetic engineering technology. It is derived from the pancreas, but it is not extracted from the animal body, but obtained by recombinant expression in microorganisms or other cell systems. This enzyme is widely used in protein engineering, drug synthesis, biochemical research and other fields.

USD3480.00

addToCart

Add To Cart

industry 12 Feb 2024

industry Medical Devices & Consumables

new_biaoQian Recombinant Trypsin EDTA Solution for Cell Dissociation

The global Recombinant Trypsin EDTA Solution for Cell Dissociation market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

USD4480.00

addToCart

Add To Cart

industry 18 Mar 2023

industry Pharma & Healthcare

new_biaoQian Recombinant Trypsin

Recombinant Trypsin is a genetically engineered protein expressed in E-Coli. As such it is totally animal free, free from contaminating enzymes like chymotrysin as well as protease inhibitors. It is highly stable with a high purity. It is widely used in insulin manufacturing, Vaccines Manufacturing and cell culture applications.

USD3480.00

addToCart

Add To Cart

Go To Page

Confirm